Ukraine’s reformed patent law comes into effect due to advocacy work
Dolutegravir (DTG) is widely available in Ukraine due to advocacy work. It provides a framework to prevent unlawful patents and monopolies on essential drugs, which have restricted access to life-saving treatment in the country.